Arca
Skip to content
Tools
Tools

HYDROMORPHONE HCL-BUPIVACAINE HCL-FENTANYL PF INJECTABLE 21 mL syringe in various…

Recall D-0711-2021, part of FDA recall event 88291. See Med Shop Total Care's company page.

Med Shop Total Care Inc. started this Class I drug recall on Oct 5, 2020 (voluntary: firm initiated); FDA lists it as terminated, terminated Aug 17, 2023.

  • Classification: Class I
  • Started: Oct 5, 2020
  • Status: Terminated
  • Products in this event: 14

Why It Was Recalled

Class I

Non-Sterility

Record

Product
HYDROMORPHONE HCL-BUPIVACAINE HCL-FENTANYL PF INJECTABLE 21 mL syringe in various strengths, a)10MG-20MG-100MCG/ML, b) 20MG-10MG-450MCG/ML, c) 13.3MG-3MG-3000MCG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605
Quantity
84 mL
Lots and codes
Lot #: a) 09282020@66, BUD 10/27/2020, 09302020@42, BUD 10/29/2020, b) 09282020@79, c) 09292020@32, BUD 10/27/2020 09282020@66 09302020@42 09282020@79 09292020@32 10/27/2020 10/29/2020 10/27/2020 10/27/2020
Distribution
Texas and Puerto Rico
Recalling firm
Med Shop Total Care Inc., Longview, TX, United States
How the firm notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
FDA classified
Aug 9, 2021

Other Products in This Recall

Recall event 88291

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.